There are trials underway, and we expect that the vaccine will become available for certain age groups of children and for adolescents by late 2021 or early 2022
10.1167/tvst.8.4.23 75 VukojevicJ.SiroglavicM.KasnikK.KraljT.StancicD.KokotA.et al (2018)
Despite their importance, GLP-1RAs were, until recently, only available for subcutaneous administration, which may have contributed to lower usage rates versus orally available therapies (i.e., SGLT2is and DPP-4 inhibitors) [6, 7, 34,35,36,37]
This distinction matters for peptide research applications
Storage Reconstituted MT-2 should be refrigerated and used within 46 weeks